BioNeutra Global (TSXV:BGA) Additional Paid-In Capital : C$1.60 Mil(As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Additional Paid-In Capital?

BioNeutra Global's quarterly additional paid-in capital increased from Sep. 2023 (C$1.60 Mil) to Dec. 2023 (C$1.60 Mil) but then stayed the same from Dec. 2023 (C$1.60 Mil) to Mar. 2024 (C$1.60 Mil).

BioNeutra Global's annual additional paid-in capital increased from Dec. 2021 (C$1.32 Mil) to Dec. 2022 (C$1.59 Mil) and increased from Dec. 2022 (C$1.59 Mil) to Dec. 2023 (C$1.60 Mil).

BioNeutra Global Additional Paid-In Capital Historical Data

The historical data trend for BioNeutra Global's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Additional Paid-In Capital Chart

BioNeutra Global Annual Data

Trend

Feb14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1.14

1.32

1.59

1.60

BioNeutra Global Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1.60	1.60	1.60	1.60	1.60

BioNeutra Global Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

BioNeutra Global Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNeutra Global (TSXV:BGA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BGACF:USA

Address

9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4

Website

http://www.bioneutra.ca

BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

Executives

Monica Barclay

Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines